Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...

The research shows that germline and somatic variability work together to initiate and drive progression of prostate cancer. This discovery could one day help improve how doctors predict and treat ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes. Conducted by ...

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...

Rishi Sunak met workers developing a new blood test for the disease last week Former prime minister Rishi Sunak has said he is "honoured" to become a prostate cancer charity ambassador.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Former prime minister Rishi Sunak has said he is "honoured" to become a prostate cancer charity ambassador. He will support Prostate Cancer Research's campaign to introduce a national screening ...

The latest figures on prostate cancer are shocking: it has officially overtaken breast cancer as the most commonly diagnosed cancer in England, according to NHS figures. These show a massive 25 ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and personalised treatment. The test identifies cancerous cells, signs of early and ...

SCIENTISTS have a developed a "game-changing" new "super test" that can diagnose prostate cancer with 96 per cent accuracy. Olympic cycling legend Sir Chris Hoy - who revealed he had terminal ...

Isotopia, a leading developer of innovative radio-pharmaceuticals, has officially launched Isoprotrace® in Germany. DSD ...